As of September 30, 2025, BillionToOne held approximately $195.2 million in cash and cash equivalents. The Company raised gross proceeds of $314.0 million from its IPO, which closed on November 7, ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

A stronger domestic industry will not just boost the local industry and reduce the import bill but also ensure that ...

Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...

Shard Diagnostic has become the latest company to join the University of Nottingham's investment portfolio, supported through ...

The molecular biosensors market is ripe with opportunities due to rising demand for rapid, accurate diagnostics for chronic ...

Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify ...

The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...

Testmate Health and Intermountain Health have entered a strategic collaboration and investment agreement to expedite the ...

Researchers at the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh discovered a promising new biomarker of "complicated" mild- to severe-pediatric traumatic brain injury, or TBI.

Ensuring blood safety remains one of the most effective defenses against transfusion-transmitted infections. By enhancing screening accuracy and enabling laboratories to detect HBV, HCV, HIV-1, and ...